-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DEF5MbAkdHwcSN49V3rgkEbb9JVX+FLta7tuX8Bf1f4ItLAsYcqfFJ0SwdTxg2Al 0bedUFxzHaMmdbh6K1j01A== 0001203944-09-000009.txt : 20090113 0001203944-09-000009.hdr.sgml : 20090113 20090113122806 ACCESSION NUMBER: 0001203944-09-000009 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090113 DATE AS OF CHANGE: 20090113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RAPTOR PHARMACEUTICALS CORP. CENTRAL INDEX KEY: 0001203944 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980379351 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-152420 FILM NUMBER: 09523327 BUSINESS ADDRESS: STREET 1: 9 COMMERCIAL BLVD, SUITE 200 CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-382-1390 MAIL ADDRESS: STREET 1: 9 COMMERCIAL BLVD, SUITE 200 CITY: NOVATO STATE: CA ZIP: 94949 FORMER COMPANY: FORMER CONFORMED NAME: HIGHLAND CLAN CREATIONS CORP. DATE OF NAME CHANGE: 20060531 FORMER COMPANY: FORMER CONFORMED NAME: HIGHLAND CLAN CREATIONS CORP DATE OF NAME CHANGE: 20021106 424B3 1 prosup011309.htm RAPTOR PROPSECTUS SUPPLEMENT NO. 1 01/13/09

 

 

Filed Pursuant to Rules 424(b)(3) and 424(c)

 

Registration Statement No. 333-152420

 

 

Prospectus Supplement No. 1

 

to

 

Prospectus Dated December 12, 2008

 

RAPTOR PHARMACEUTICALS CORP.

 

We are supplementing our Prospectus dated December 12, 2008, as originally filed as part of our Registration Statement on Form S-1 (Reg. No. 333-152420) with the Securities and Exchange Commission (the “Commission”) on July 18, 2008, as amended by that certain Pre-Effective Amendment No. 1 to the Form S-1 on Form S-1/A, as filed with the Commission on August 1, 2008 (and effective as of August 5, 2008), and as amended by that certain Post-Effective Amendment No. 1 to the Form S-1 on Form S-1/A, as filed with the Commission on November 26, 2008 (and effective as of December 11, 2008), relating to the resale by certain selling stockholders of up to 47,725,000 shares of common stock (the “Prospectus”), to provide information contained in our Quarterly Report on Form 10-Q filed with the Commission on January 13, 2009 for the quarterly period ended November 30, 2008, a copy of which is attached hereto (without exhibits) and incorporated herein by reference.

 

You should read this Prospectus Supplement No. 1 in conjunction with the Prospectus which is required to be delivered with this Prospectus Supplement No. 1. This Prospectus Supplement No. 1 is qualified by reference to the Prospectus and any earlier supplement, except to the extent the information in this supplement updates or supersedes the information contained in the Prospectus or earlier supplement.

 

INVESTING IN OUR COMMON STOCK INVOLVES A HIGH DEGREE OF RISK. SEE “RISK FACTORS” BEGINNING ON PAGE 6 OF THE PROSPECTUS FOR A DISCUSSION FOR THE RISKS ASSOCIATED WITH OUR BUSINESS.

 

RECENT DEVELOPMENTS

 

---------------------------

 

QUARTERLY REPORT ON FORM 10-Q

 

On January 12, 2009, we filed the attached quarterly report on Form 10-Q for the quarterly period ended November 30, 2008 with the Commission.

 

---------------------------

 

 

 

 

Neither the Commission nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus Supplement No. 1 is truthful or complete. Any representation to the contrary is a criminal offense.

 

The date of this Prospectus Supplement is January 13, 2009.

 

 

 

 

 

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----